Sociedad Química y Minera de Chile S.A. (SQM-B.SN)
Santiago, CL
Sociedad Química y Minera de Chile S.A. (SQM) specializes in the production and global distribution of a diverse range of items, including advanced plant nutrients, various iodine and lithium derivatives, potassium chloride, potassium sulfate, and a selection of industrial chemicals. Its specialized plant nutrition offerings feature compounds like potassium nitrate, sodium nitrate, sodium potassium nitrate, custom fertilizer blends, and other high-performance fertilizers. Iodine and its compounds are supplied for a broad spectrum of uses across medical, pharmaceutical, agricultural, and industrial fields; these applications encompass x-ray contrast media, polarizing films for LCD and LED screens, antiseptics, biocides, disinfectants, pharmaceutical synthesis, electronic components, pigments, and dye constituents. SQM's lithium carbonates are essential for numerous applications, such as electrochemical materials for batteries, frits used in the ceramic and enamel sectors, heat-resistant glass, chemicals for air conditioning, continuous casting powders for steel extrusion, the primary aluminum smelting process, pharmaceuticals, and as an ingredient in gunpowder production. Additionally, the company furnishes lithium hydroxide, crucial for the lubricating greases industry and as a key material for battery cathodes. Potassium chloride and potassium sulfate are provided to support the cultivation of various crops, including corn, rice, sugar, soybeans, and wheat. The industrial chemical portfolio includes sodium nitrate, potassium nitrate, potassium chloride, and solar salts, along with other fertilizer types and blended products. Established in 1960 and headquartered in Santiago, Chile, SQM maintains operations and distribution networks spanning Chile, the broader Latin America and Caribbean region, Europe, North America, Asia, and other international markets.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.92% | +3.36% | -7.09% | +13.10% | +28.97% | +21.45% | +146.48% | +38.93% | +143.74% | +408.98% | +4,405.97% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +7.2%+6.3% Q1'26: +69.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +16.5%+252.8% ★ Q1'26: +166.7% (vs Q1'25)
-
FCF margin Chemicals - Specialty: +27.4%+13.8% Q1'26: +18.9% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +9.5%+24.8% ★ Q1'26: +42.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +6.2%+7.9% ★ Q1'26: +18.8% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.0%+0.0% Q1'26: -0.3% (vs Q1'25)
-
Debt / EBITDA Chemicals - Specialty: 0.21×2.89× Q1'26: 1.73× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 15 Rev. Ana. 1 EPS Ana. |
Dec 2027 15 Rev. Ana. 1 EPS Ana. |
Dec 2028 6 Rev. Ana. 1 EPS Ana. |
Dec 2029 11 Rev. Ana. 1 EPS Ana. |
Dec 2030 7 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.87B
est.
|
2.03B
est.
|
2.23B
est.
|
1.94B
est: 2.19B (-11.4%)
|
1.82B
est: 1.82B (0.0%)
|
2.86B
est: 2.56B (+11.9%)
|
10.71B
est: 10.36B (+3.4%)
|
7.47B
est: 7.84B (-4.8%)
|
4.53B
est: 4.34B (+4.3%)
|
4.81B
est: 4.46B (+8.0%)
|
7.09B
5.36B – 7.90B
+59.2% YoY
|
7.07B
5.10B – 8.65B
-0.4% YoY
|
7.53B
5.57B – 8.80B
+6.5% YoY
|
8.73B
6.45B – 10.19B
+15.9% YoY
|
8.41B
6.21B – 9.82B
-3.7% YoY
|
| EBITDA |
686.72M
est.
|
744.78M
est.
|
817.93M
est.
|
633.07M
est: 805.84M (-21.4%)
|
326.81M
est: 668.05M (-51.1%)
|
926.12M
est: 939.83M (-1.5%)
|
5.58B
est: 3.81B (+46.6%)
|
2.94B
est: 2.88B (+1.9%)
|
1.17B
est: 1.60B (-26.8%)
|
1.64B
est: 1.64B (+0.4%)
|
2.61B
1.97B – 2.90B
+59.2% YoY
|
2.60B
1.88B – 3.18B
-0.4% YoY
|
2.77B
2.05B – 3.23B
+6.5% YoY
|
3.21B
2.37B – 3.75B
+15.9% YoY
|
3.09B
2.28B – 3.61B
-3.7% YoY
|
| EBIT |
650.71M
est.
|
705.73M
est.
|
775.04M
est.
|
442.53M
est: 763.59M (-42.0%)
|
323.68M
est: 633.02M (-48.9%)
|
923.26M
est: 890.55M (+3.7%)
|
5.58B
est: 3.61B (+54.7%)
|
2.93B
est: 2.73B (+7.4%)
|
1.16B
est: 1.51B (-23.1%)
|
1.20B
est: 1.55B (-23.0%)
|
2.47B
1.87B – 2.75B
+59.2% YoY
|
2.46B
1.78B – 3.01B
-0.4% YoY
|
2.62B
1.94B – 3.06B
+6.5% YoY
|
3.04B
2.25B – 3.55B
+15.9% YoY
|
2.93B
2.16B – 3.42B
-3.7% YoY
|
| Net Income |
329.71M
est.
|
444.85M
est.
|
470.42M
est.
|
278.12M
est: 344.80M (-19.3%)
|
164.52M
est: 196.13M (-16.1%)
|
585.45M
est: 492.94M (+18.8%)
|
3.91B
est: 3.78B (+3.4%)
|
2.01B
est: 2.33B (-13.5%)
|
-404.36M
est: -374.11M (-8.1%)
|
618.53M
est: 616.36M (+0.4%)
|
1.58B
1.04B – 1.92B
+155.8% YoY
|
1.59B
1.05B – 1.93B
+0.5% YoY
|
1.56B
1.03B – 1.90B
-1.7% YoY
|
1.52B
1.00B – 1.85B
-2.5% YoY
|
1.82B
1.20B – 2.21B
+19.4% YoY
|
| SGA |
44.73M
est.
|
48.51M
est.
|
53.28M
est.
|
122.72M
est: 52.49M (+133.8%)
|
116.01M
est: 43.52M (+166.6%)
|
90.36M
est: 61.22M (+47.6%)
|
79.16M
est: 247.86M (-68.1%)
|
74.95M
est: 187.70M (-60.1%)
|
133.21M
est: 103.92M (+28.2%)
|
198.62M
est: 106.69M (+86.2%)
|
169.82M
128.40M – 189.05M
+59.2% YoY
|
169.17M
122.15M – 207.01M
-0.4% YoY
|
180.23M
133.22M – 210.54M
+6.5% YoY
|
208.87M
154.39M – 243.99M
+15.9% YoY
|
201.24M
148.75M – 235.08M
-3.7% YoY
|
| EPS |
1.15
est.
|
1.56
est.
|
1.65
est.
|
1.06
est: 1.21 (-12.2%)
|
0.63
est: 0.69 (-8.2%)
|
2.05
est: 1.73 (+18.8%)
|
13.68
est: 13.23 (+3.4%)
|
7.05
est: 8.15 (-13.5%)
|
-1.42
est: -1.31 (-8.4%)
|
2.17
est: 2.16 (+0.6%)
|
5.52
3.65 – 6.73
+155.8% YoY
|
5.55
3.67 – 6.76
+0.5% YoY
|
5.46
3.61 – 6.65
-1.7% YoY
|
5.32
3.52 – 6.49
-2.5% YoY
|
6.36
4.20 – 7.74
+19.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | B | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | B- | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-15 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-14 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-13 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-10 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ana Maria Munoz | Risk, Compliance & Internal Audit Manager | — | female |
| Carlos Diaz Ortiz | General Manager of Nova Andino Lithium | — | male |
| Gerardo Illanes G. | Chief Financial Officer & Vice President of Finance | — | male |
| Gonzalo Aguirre T. | Vice President of Legal & General Counsel | — | male |
| Irina Axenova | Head of Investor Relations | — | female |
| Nelson Torres | Vice President of Operations, Mine & Leaching, SQM, Iodine and Plant Nutrition | — | — |
| Pablo Andres Altimiras Ceardi | General Manager of Iodine - Plant Nutrition Division | — | — |
| Ricardo Ramos Rodríguez | General Manager | — | male |
| Rodrigo Jasen | Vice President People & Culture | — | — |
| Trinidad Reyes | Director of Development | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SQM-B.SN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
